StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
InvestmentApr 16, 2026, 05:31 PM

MeiraGTx to sell 11.1M ordinary shares at $9.00, raising $93.3M

AI Summary

MeiraGTx Holdings plc entered into an underwriting agreement to sell 11,111,111 ordinary shares at an offering price of $9.00 per share. The company expects to receive net proceeds of approximately $93.3 million from this offering. These funds are intended for general corporate purposes, including working capital and capital expenditures. MeiraGTx believes the proceeds, combined with existing cash, will fund its operating expenses and capital expenditure requirements into the second half of 2028.

Key Highlights

  • Offering 11,111,111 ordinary shares.
  • Shares priced at $9.00 per share.
  • Expected net proceeds of approximately $93.3 million.
  • Funds operations into the second half of 2028.